Botulinum toxin for Raynaud's phenomenon associated with systemic sclerosis: comment on the article by Senet et al

Arthritis Rheumatol. 2023 Mar;75(3):486. doi: 10.1002/art.42379. Epub 2023 Jan 19.

Authors

Hanlin Yin¹, Bei Liu¹, Qianqian Li¹, Qingran Yan¹, Liangjing Lu¹

Affiliation

¹ Department of Rheumatology Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

PMID: 36209513
DOI: 10.1002/art.42379

No abstract available

Publication types

Letter
Comment

MeSH terms

Botulinum Toxins*
Humans
Raynaud Disease* / drug therapy
Scleroderma, Systemic* / complications
Scleroderma, Systemic* / drug therapy

Substances

Botulinum Toxins